Search
                    Angioedema Clinical Trials
A listing of 2  Angioedema  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 2 of 2
        
        
    
                There are currently 2 active clinical trials seeking participants for Angioedema research studies. The states with the highest number of trials for Angioedema participants are Ohio, California, Maryland and Michigan.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
                                
            
            
        Recruiting
                            
            
                use of lanadelumab in patients with acquired angioedema             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/24/2025
            
            Locations: Bernstein Clinical Research Center, LLC, Cincinnati, Ohio         
        
        
            Conditions: Angioedema
        
            
        
    
                
                                    Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
                                
            
            
        Recruiting
                            
            
                To assess the efficacy of prophylactic treatment with deucrictibant extended release (XR) tablet versus placebo in preventing angioedema attacks, and to also assess the efficacy of deucrictibant soft capsules as on-demand treatment versus placebo in achieving angioedema symptom relief during acute attacks.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 75 years
            Trial Updated:
                06/23/2025
            
            Locations: Institute For Asthma & Allergy, Wheaton, Maryland         
        
        
            Conditions: Hereditary Angioedema (HAE), Angioedema, Bradykinin-mediated Angioedema, C1 Inhibitor Deficiency
        
            
        
    1 - 2 of 2
            
            
        